标题
Pleiotropic Mechanisms for the Glucose-Lowering Action of DPP-4 Inhibitors
作者
关键词
-
出版物
DIABETES
Volume 63, Issue 7, Pages 2196-2202
出版商
American Diabetes Association
发表日期
2014-06-25
DOI
10.2337/db14-0052
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade
- (2013) B. A. Aulinger et al. DIABETES
- Effects of Sitagliptin and Metformin Treatment on Incretin Hormone and Insulin Secretory Responses to Oral and "Isoglycemic" Intravenous Glucose
- (2013) I. Vardarli et al. DIABETES
- Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects
- (2013) L. Ohlsson et al. DIABETES OBESITY & METABOLISM
- Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model
- (2013) B. A. Omar et al. DIABETOLOGIA
- Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety
- (2013) Carolyn F Deacon et al. EXPERT OPINION ON PHARMACOTHERAPY
- The DPP-4 Inhibitor Linagliptin Restores β-Cell Function and Survival in Human Isolated Islets Through GLP-1 Stabilization
- (2013) Payal Shah et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis
- (2012) C. F. Deacon et al. DIABETES OBESITY & METABOLISM
- Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study
- (2012) B. Eliasson et al. DIABETOLOGIA
- Direct effect of GLP-1 infusion on endogenous glucose production in humans
- (2012) M. Seghieri et al. DIABETOLOGIA
- A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets
- (2012) P. Marchetti et al. DIABETOLOGIA
- Mechanisms for the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes
- (2012) Elza Muscelli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans
- (2011) M. Christensen et al. DIABETES
- Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs
- (2011) K. R. Hjøllund et al. DIABETOLOGIA
- Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus—an adaptive response to hyperglycaemia?
- (2011) A. M. K. Hansen et al. DIABETOLOGIA
- Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival
- (2011) Z. Liu et al. DIABETOLOGIA
- Physiological and Pharmacological Mechanisms through which the DPP-4 Inhibitor Sitagliptin Regulates Glycemia in Mice
- (2011) Aurélie Waget et al. ENDOCRINOLOGY
- Inhibition of DPP-4 with Vildagliptin Improved Insulin Secretion in Response to Oral as well as “Isoglycemic” Intravenous Glucose without Numerically Changing the Incretin Effect in Patients with Type 2 Diabetes
- (2011) Irfan Vardarli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Intraportal administration of DPP-IV inhibitor regulates insulin secretion and food intake mediated by the hepatic vagal afferent nerve in rats
- (2011) Kansuke Fujiwara et al. JOURNAL OF NEUROCHEMISTRY
- Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice
- (2010) A. D. Dobrian et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes
- (2010) M. Salehi et al. DIABETES
- Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
- (2010) C. F. Deacon DIABETES OBESITY & METABOLISM
- Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus
- (2009) K. Aaboe et al. DIABETES OBESITY & METABOLISM
- Inhibition of Dipeptidyl Peptidase-4 by Vildagliptin During Glucagon-Like Peptide 1 Infusion Increases Liver Glucose Uptake in the Conscious Dog
- (2008) D. S. Edgerton et al. DIABETES
- Dipeptidyl Peptidase IV Inhibition With MK0431 Improves Islet Graft Survival in Diabetic NOD Mice Partially via T-Cell Modulation
- (2008) S.-J. Kim et al. DIABETES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started